Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (4)
2024 (528)
2023 (586)
2022 (724)
2021 (1399)
2020 (842)
All (4083)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Jernbom Falk A
JSON
CSV
XLSX
TXT
Family name
Jernbom Falk
Given name
August
Initials
A
ORCID
ORCID
0000-0002-7773-1851
Affiliations
Division of Affinity Proteomics Department of Protein Science KTH Royal Institute of Technology SciLifeLab Stockholm Sweden.
7 publications
PubMed
DOI
Crossref
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19.
Jernbom AF
,
Skoglund L
,
Pin E
, ...,
Månberg A
,
Nilsson P
Nat Commun
15
(1) 8941 [2024-10-17; online 2024-10-17]
PubMed
DOI
Crossref
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Laurén I
, Havervall S,
Ng H
, ..., Thålin C,
Mangsbo S
Immun Inflamm Dis
10
(4) e595 [2022-04-00; online 2022-03-30]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: High-throughput and high-content serology
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S
,
Jernbom Falk A
,
Klingström J
, ...,
Nilsson P
, Thålin C
PLoS One
17
(1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S
,
Ng H
,
Jernbom Falk A
, ...,
Hober S
,
Thålin C
J Intern Med
291
(1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Drug discovery and repurposing of drugs
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Research Area: Viral sequence evolution
PubMed
DOI
Crossref
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM
, Havervall S, Laurén I, ..., Klingström J, Thålin C
PLoS One
16
(9) e0258041 [2021-09-30; online 2021-09-30]
Category: Biochemistry
Category: Health
Category: Imaging
Type: Journal article
PubMed
DOI
Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S
, Hellström C,
Olofsson J
, ...,
Hedhammar M
,
Nilsson P
Clin Transl Immunol
10
(7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
PubMed
DOI
Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS
, Havervall S,
Månberg A
, ...,
Hober S
,
Thålin C
Nat Commun
11
(1) 5064 [2020-10-08; online 2020-10-08]
Category: Health
Category: Serology
Funder: H2020
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: High-throughput and high-content serology
Research Area: Host cell systems biology and targets
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.1